Abstract
Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration. © 2011 Schumi and Wittes; licensee BioMed Central Ltd.
Cite
CITATION STYLE
APA
Schumi, J., & Wittes, J. T. (2011, May 3). Through the looking glass: Understanding non-inferiority. Trials. https://doi.org/10.1186/1745-6215-12-106
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free